Coinbase Founder’s Longevity Startup Triples in Value
Now worth $3.1 billion, NewLimit plans to test its RNA therapy in alcohol-related liver-disease patients next year.
Connecting Global Economies
Now worth $3.1 billion, NewLimit plans to test its RNA therapy in alcohol-related liver-disease patients next year.
With so much data at its fingertips, artificial intelligence will allow more-informed interest-rate decisions and better economic modeling.
Plus, Anthropic gets the IPO ball rolling and Nvidia makes a play for the PC market.
The order is a slimmed-down version of the one Trump shelved last month and asks AI companies to give the administration access to powerful models 30 days before public release.
In AI, money talks. The ability to tap stock market capital is important again, after a quarter of a century of being all but irrelevant.
In AI, money talks. The ability to tap stock market capital is important again, after a quarter of a century of being all but irrelevant.
Plus, Huawei will likely trail rivals by six to eight years by 2031 despite its innovations.
Jensen Huang says Marvell Technology could be the next chip firm to join the trillion-dollar club, predicting a surge in demand for AI hardware fueled by the emergence of autonomous … Read More
The world’s only $5 trillion company can sell the concept that AI computing won’t be confined to data centers.
The experiment offers one of the first large-scale looks at the effect that coordinated AI adoption can have on students’ reasoning, retention and confidence.